23 results
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
6 May 24
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
7:03am
workforce reduction implemented in the first quarter of 2024.
Based on the company’s disciplined approach to capital allocation, and the adjusted
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
26 Feb 24
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
7:05am
.
This operating expense outlook does not reflect non-cash stock compensation expense, or one-time expenses related to the previously announced workforce
8-K
EX-99.1
cz9 xgcbhzbtm
7 Dec 12
Biocryst Pharmaceuticals Announces Focused Corporate Strategy
12:00am
8-K
5pil3co bf
7 Dec 12
Biocryst Pharmaceuticals Announces Focused Corporate Strategy
12:00am
8-K
EX-99.1
5eoc20ookcdj i5sp
31 Oct 08
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
x7qcp9cjkfbht mdr
4 Feb 04
Other events
12:00am
8-K
EX-99.1
k649m97
16 Dec 03
Other events
12:00am